202 related articles for article (PubMed ID: 28455960)
1. A-to-I RNA editing of BLCAP lost the inhibition to STAT3 activation in cervical cancer.
Chen W; He W; Cai H; Hu B; Zheng C; Ke X; Xie L; Zheng Z; Wu X; Wang H
Oncotarget; 2017 Jun; 8(24):39417-39429. PubMed ID: 28455960
[TBL] [Abstract][Full Text] [Related]
2. A-to-I RNA editing of BLCAP promotes cell proliferation by losing the inhibitory of Rb1 in colorectal cancer.
Han F; Hu M; Zhang L; Fan X; Wang J; Lou Z; Wang S; Chen L; Ye Y; Ding Y; Jiao H
Exp Cell Res; 2022 Aug; 417(2):113209. PubMed ID: 35605649
[TBL] [Abstract][Full Text] [Related]
3. Human BLCAP transcript: new editing events in normal and cancerous tissues.
Galeano F; Leroy A; Rossetti C; Gromova I; Gautier P; Keegan LP; Massimi L; Di Rocco C; O'Connell MA; Gallo A
Int J Cancer; 2010 Jul; 127(1):127-37. PubMed ID: 19908260
[TBL] [Abstract][Full Text] [Related]
4. RNA over-editing of BLCAP contributes to hepatocarcinogenesis identified by whole-genome and transcriptome sequencing.
Hu X; Wan S; Ou Y; Zhou B; Zhu J; Yi X; Guan Y; Jia W; Liu X; Wang Q; Qi Y; Yuan Q; Huang W; Liao W; Wang Y; Zhang Q; Xiao H; Chen X; Huang J
Cancer Lett; 2015 Feb; 357(2):510-9. PubMed ID: 25499081
[TBL] [Abstract][Full Text] [Related]
5. Identification of BLCAP as a novel STAT3 interaction partner in bladder cancer.
Gromova I; Svensson S; Gromov P; Moreira JMA
PLoS One; 2017; 12(11):e0188827. PubMed ID: 29190807
[TBL] [Abstract][Full Text] [Related]
6. Stat3 activation in human endometrial and cervical cancers.
Chen CL; Hsieh FC; Lieblein JC; Brown J; Chan C; Wallace JA; Cheng G; Hall BM; Lin J
Br J Cancer; 2007 Feb; 96(4):591-9. PubMed ID: 17311011
[TBL] [Abstract][Full Text] [Related]
7. [Inhibitory effect of bladder cancer related protein gene on HeLa cell proliferation].
Zuo ZH; Zhao M; Liu J; Wei Y; Wu XX
Ai Zheng; 2006 Jul; 25(7):811-7. PubMed ID: 16831269
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of bladder cancer-related protein gene: a putative cervical cancer tumor suppressor gene in cervical carcinoma.
Zuo Z; Zhao M; Liu J; Gao G; Wu X
Tumour Biol; 2006; 27(4):221-6. PubMed ID: 16675915
[TBL] [Abstract][Full Text] [Related]
9. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
Ganem NS; Ben-Asher N; Lamm AT
Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
[TBL] [Abstract][Full Text] [Related]
10. Evolutionarily conserved human targets of adenosine to inosine RNA editing.
Levanon EY; Hallegger M; Kinar Y; Shemesh R; Djinovic-Carugo K; Rechavi G; Jantsch MF; Eisenberg E
Nucleic Acids Res; 2005; 33(4):1162-8. PubMed ID: 15731336
[TBL] [Abstract][Full Text] [Related]
11. Alternative Splicing of STAT3 Is Affected by RNA Editing.
Goldberg L; Abutbul-Amitai M; Paret G; Nevo-Caspi Y
DNA Cell Biol; 2017 May; 36(5):367-376. PubMed ID: 28278381
[TBL] [Abstract][Full Text] [Related]
12. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
Ren C; Cheng X; Lu B; Yang G
Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
[TBL] [Abstract][Full Text] [Related]
13. CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma.
Mo XT; Leung TH; Tang HW; Siu MK; Wan PK; Chan KK; Cheung AN; Ngan HY
Br J Cancer; 2020 Sep; 123(5):833-843. PubMed ID: 32507856
[TBL] [Abstract][Full Text] [Related]
14. Blockage of PTPRJ promotes cell growth and resistance to 5-FU through activation of JAK1/STAT3 in the cervical carcinoma cell line C33A.
Yan CM; Zhao YL; Cai HY; Miao GY; Ma W
Oncol Rep; 2015 Apr; 33(4):1737-44. PubMed ID: 25634668
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6-induced epithelial-mesenchymal transition through signal transducer and activator of transcription 3 in human cervical carcinoma.
Miao JW; Liu LJ; Huang J
Int J Oncol; 2014 Jul; 45(1):165-76. PubMed ID: 24806843
[TBL] [Abstract][Full Text] [Related]
16. MUC16 facilitates cervical cancer progression via JAK2/STAT3 phosphorylation-mediated cyclooxygenase-2 expression.
Shen H; Guo M; Wang L; Cui X
Genes Genomics; 2020 Feb; 42(2):127-133. PubMed ID: 31736008
[TBL] [Abstract][Full Text] [Related]
17. A-to-I RNA editing - thinking beyond the single nucleotide.
Ganem NS; Lamm AT
RNA Biol; 2017 Dec; 14(12):1690-1694. PubMed ID: 28820319
[TBL] [Abstract][Full Text] [Related]
18. Autocrine STAT3 activation in HPV positive cervical cancer through a virus-driven Rac1-NFκB-IL-6 signalling axis.
Morgan EL; Macdonald A
PLoS Pathog; 2019 Jun; 15(6):e1007835. PubMed ID: 31226168
[TBL] [Abstract][Full Text] [Related]
19. To edit or not to edit: regulation of ADAR editing specificity and efficiency.
Deffit SN; Hundley HA
Wiley Interdiscip Rev RNA; 2016; 7(1):113-27. PubMed ID: 26612708
[TBL] [Abstract][Full Text] [Related]
20. Alterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis.
Shishodia G; Shukla S; Srivastava Y; Masaldan S; Mehta S; Bhambhani S; Sharma S; Mehrotra R; Das BC; Bharti AC
Mol Cancer; 2015 Jun; 14():116. PubMed ID: 26051842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
